文献速递心脑血管急症重症综合管理与镇静镇痛

衰弱与心源性休克长期死亡率:一项跨国多中心队列研究

Frailty and long-term mortality in cardiogenic shock: a binational multicentre cohort study.
PubMed 文献 · Crit Care · 2026-03-25
一句话结论心源性休克患者中,衰弱与出院后死亡风险独立相关(aHR 2.27),支持将衰弱评估纳入ICU风险分层和出院后照护规划。

这项回顾性队列研究纳入澳大利亚和新西兰188个ICU的71,359例成人(≥16岁)心源性休克患者,均有临床衰弱量表(CFS)记录,其中11,087例存在衰弱。校正Cox模型显示衰弱与死亡风险升高相关(aHR 2.27,95%CI 2.05–2.51),呈非线性递增关系;时变分析显示ICU入住约6个月时风险最高(HR 3.71,95%CI 3.29–4.18)。ICU出院时landmark分析中衰弱仍与死亡相关(aHR 3.13,95%CI 2.82–3.48)。作者认为这些发现支持将衰弱评估整合进ICU风险分层和出院后照护规划。

要点

  • 在71,359例心源性休克患者中,衰弱与死亡风险升高独立相关(aHR 2.27,95%CI 2.05–2.51),且呈非线性递增。
  • 时变分析显示衰弱在ICU入住约6个月时死亡风险最高(HR 3.71,95%CI 3.29–4.18)。
  • ICU出院时landmark分析中衰弱仍与死亡相关(aHR 3.13,95%CI 2.82–3.48),提示出院后风险持续。
  • 衰弱与死亡的关联在缺血性病因者中强于非缺血性病因者,在男性中强于女性。
  • 作者认为上述发现支持将衰弱评估纳入ICU风险分层和出院后照护规划。

适用人群与场景

  • 澳大利亚和新西兰188个ICU中2017–2023年收治的成人(≥16岁)心源性休克患者,且有临床衰弱量表(CFS)记录。

诊断标准与关键阈值

  • 使用临床衰弱量表(CFS)记录衰弱状态;原文未报告具体CFS界值。

研究设计与关键结果

  • 研究类型:回顾性队列研究,数据来自澳大利亚和新西兰重症监护学会成人患者数据库,覆盖188个ICU。
  • 样本量:71,359例,中位年龄68.6岁,男性70.0%;其中11,087例存在衰弱。
  • 主要终点:衰弱与死亡风险升高相关(校正HR 2.27,95%CI 2.05–2.51),呈非线性递增关系,敏感性分析结果一致。
  • 时变分析:衰弱在ICU入住约6个月时死亡风险最高(HR 3.71,95%CI 3.29–4.18)。
  • 亚组:衰弱与死亡的关联在缺血性病因者中强于非缺血性病因者,在男性中强于女性。
  • ICU出院时landmark分析:衰弱仍与死亡相关(校正HR 3.13,95%CI 2.82–3.48)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,上述发现支持将衰弱评估整合进ICU风险分层和出院后照护规划。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Frailty is increasingly recognised as a prognostic marker in cardiovascular disease, but its role in cardiogenic shock is less defined. METHODS: In this retrospective cohort study across 188 intensive care units (ICUs), we analysed data from the Australia and New Zealand Intensive Care Society Adult Patient Database on adults (≥ 16 years) with admitted with cardiogenic shock between 2017–2023, and a documented Clinical Frailty Scale (CFS). The primary outcome was death at up to four years using an adjusted Cox proportional hazards model, which we also assessed using a time-varying model. We conducted subgroup analyses based on age, sex, aetiology of cardiogenic shock, and a landmark survival analysis at ICU discharge. RESULTS: We included 71,359 patients (median age 68.6 years, 70.0% males); 11,087 had frailty. Frailty was associated with a higher hazard of death (adjusted Hazard ratio [aHR]: 2.27, 95% confidence interval [CI]: 2.05–2.51) in a non-linear incremental fashion; this was consistent across sensitivity analyses. Time-varying analysis found that frailty demonstrated the highest hazard for death at approximately six months post-ICU admission (HR: 3.71, 95%-CI: 3.29–4.18). Frailty was more strongly associated with death in patients with ischaemic than non-ischaemic cardiogenic shock, and in males more than females. Frailty was also associated with death in a landmark survival analysis at ICU discharge (aHR: 3.13, 95%-CI: 2.82–3.48). CONCLUSIONS: Frailty is associated with mortality beyond ICU discharge in cardiogenic shock in a non-linear, stepwise fashion. These findings support the integration of frailty assessment into ICU risk stratification and post-discharge care planning.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Ling RR, Lim SL, Kaye DM, et al. Frailty and long-term mortality in cardiogenic shock: a binational multicentre cohort study. Crit Care. 2026. PMID: 41882780. doi:10.1186/s13054-026-05962-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。